In the latest session, Kura Oncology Inc (NASDAQ: KURA) closed at $21.04 down -5.82% from its previous closing price of $22.34. In other words, the price has decreased by -$1.30 from its previous closing price. On the day, 854855 shares were traded. KURA stock price reached its highest trading level at $22.22 during the session, while it also had its lowest trading level at $20.90.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Kura Oncology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.26 and its Current Ratio is at 12.26. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 22, 2023, initiated with a Buy rating and assigned the stock a target price of $26.
On August 11, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $31.
On July 27, 2023, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $10.50.Scotiabank initiated its Sector Perform rating on July 27, 2023, with a $10.50 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 30 ’24 when DALE STEPHEN sold 4,825 shares for $21.55 per share. The transaction valued at 103,980 led to the insider holds 38,817 shares of the business.
DALE STEPHEN sold 7,158 shares of KURA for $127,416 on Jan 29 ’24. The Chief Medical Officer now owns 43,642 shares after completing the transaction at $17.80 per share. On Jan 29 ’24, another insider, DOYLE THOMAS JAMES, who serves as the SVP, Finance & Accounting of the company, sold 2,318 shares for $17.80 each. As a result, the insider received 41,262 and left with 48,093 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 1.60B and an Enterprise Value of 1.20B.
Stock Price History:
Over the past 52 weeks, KURA has reached a high of $24.17, while it has fallen to a 52-week low of $7.41. The 50-Day Moving Average of the stock is 19.39, while the 200-Day Moving Average is calculated to be 12.61.
Shares Statistics:
For the past three months, KURA has traded an average of 1.51M shares per day and 1.36M over the past ten days. A total of 74.35M shares are outstanding, with a floating share count of 63.54M. Insiders hold about 16.54% of the company’s shares, while institutions hold 90.29% stake in the company. Shares short for KURA as of Feb 29, 2024 were 11.02M with a Short Ratio of 7.31, compared to 9.37M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 14.47% and a Short% of Float of 14.68%.
Earnings Estimates
There are 11 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.55 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.68, while EPS last year was -$0.5. The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.51 and low estimates of -$0.68.
Analysts are recommending an EPS of between -$2 and -$2.92 for the fiscal current year, implying an average EPS of -$2.32. EPS for the following year is -$2.46, with 13 analysts recommending between -$1.94 and -$3.1.
